Kerstin Valinder Strinnholm (born 1960) is Board member since 2015. She is also Chairwoman of the Remuneration Committee.
Her work experience includes the position as EVP Business Development for the Nycomed Group. She has also many years of experience in sales, marketing and business development from senior positions at Astra/AstraZeneca and Nycomed/Takeda.
Kerstin holds a degree from the School of Journalism at the University of Gothenburg.
Other current appointments: Chairman of the Board of Moberg Pharma AB (publ), Board member of Immedica Pharma AB, Bioservo Technologies AB (publ), Promore Pharma AB (publ), KVS Invest AB and Cavastor AB.
Holdings: 26,910 shares.
Independent in relation to the company and its management and the company’s major shareholders.